Phase II data with San Diego-based Heron Therapeutics Inc.’s pain drug HTX-011 (Zynrelef) graced the online pages of the Journal of the American Podiatric Medical Association in early January, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results